Results 181 to 190 of about 478,958 (264)

Diagnosis and management of metabolic dysfunction-associated steatohepatitis in patients with chronic hepatitis B infection. [PDF]

World J Gastroenterol
Bhatti TK, Lim JK.
europepmc   +1 more source

Chronic hepatitis B: Is it time for expanded antiviral treatment? [PDF]

World J Virol
Manrai M, Jha AA, Pachisia AV, Dawra S.
europepmc   +1 more source

Nonadherence to Antiviral Therapy Leading to Severe Hepatic Decompensation in a Patient With Chronic Hepatitis B. [PDF]

ACG Case Rep J
Ahmad S, Paracha S, Ali R, Akbar SMA, Asif MA, Saeed MO, Bai R, Afzal HMT, Shah SB, Lau DTY.   +9 more
europepmc   +1 more source

A Systematic Review and Narrative Synthesis of Factors Impacting Late Diagnosis of Chronic Hepatitis B and C. [PDF]

Health Sci Rep
Ibegu M, Keakabetse T, Nguyen ALT, Stephens N, de Graaff B.   +4 more
europepmc   +1 more source

Expression and significance of INTS10 and IRF3 in chronic hepatitis B patients. [PDF]

Front Microbiol
Ye A, Chen X, Qiu D, Wu W.
europepmc   +1 more source

Indeterminate Phase/Grey Zone of Chronic Hepatitis B: Clinical Features, Outcomes and Molecular Insights. [PDF]

Liver Int
Franzè MS, Pollicino T, Pawlotsky JM, Leroy V, Raimondo G, Amaddeo G.   +5 more
europepmc   +1 more source

Efficacy and safety of tenofovir amibufenamide in patients with chronic hepatitis B: a real-world clinical study. [PDF]

Front Med (Lausanne)
Fan R, Fan H, Tan L, Zhang J, Ai L.
europepmc   +1 more source

Refining surveillance of hepatocellular carcinoma in chronic hepatitis B through biomarker-based risk stratification. [PDF]

Hepatol Commun
Tseng TC, Huang SC, Kao JH.
europepmc   +1 more source

Chronic hepatitis B in 2025: diagnosis, treatment and future directions. [PDF]

Clin Med (Lond)
Watson AG, Mulay AS, Gill US.
europepmc   +1 more source

Global patterns and trends in kidney cancer incidence and mortality

International Journal of Cancer, EarlyView.
What's New? Decreasing mortality from kidney cancer in developed countries contrasts with persistently high or rising mortality in less‐developed regions. Factors underlying this widening gap remain incompletely understood. Using GLOBOCAN 2022 data, the present study examined patterns in kidney cancer incidence and mortality worldwide and the relation ...
Anton Barchuk, Jerome Vignat, Kari A. O. Tikkinen, Ahmedin Jemal, Freddie Bray, Ariana Znaor   +5 more
wiley   +1 more source